Presentation Individualizing Revascularization Strategy for Diabetic Patients With Multivessel CAD: FREEDOM October 17, 2019
News Daily News Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients Michael O'Riordan October 17, 2019
News Daily News DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis Michael O'Riordan October 17, 2019
News Daily News Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit Shelley Wood October 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Dramatic Swings in Household Income Linked to CVD Risk: ARIC Michael O'Riordan October 09, 2019
News Conference News TCT 2019 PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries L.A. McKeown October 04, 2019
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing Todd Neale September 28, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Daily News CMR May Help Evaluate Nonculprit Lesions in STEMI Patients Todd Neale September 19, 2019
News Conference News ESC 2019 GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS Yael L. Maxwell September 10, 2019
News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019